Aplastic Anemia Epidemiology: Incidence and Case-control
NCT00005682 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2016-02-18
Summary
To conduct incidence and case-control studies of aplastic anemia in metropolitan Bangkok, Thailand
Conditions
- Blood Disease
- Anemia, Aplastic
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Principal Investigators
-
Paul Leaverton
-
Samuel Shapiro
Eligibility
- Max Age
- 100 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1988-09-30
- Completion
- 1994-08-31
More Related Trials
-
Efficacy of Daratumumab to Overcome Platelet Transfusion Refractoriness in Patients with Aplastic Anemia
NCT05832216 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial of Hetrombopag in Healthy and Hepatic Impairment Subjects
NCT05088642 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety and Efficacy of Hetrombopag Olamine in Severe Aplastic Anemia （SAA） Patient
NCT03557099 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Long Term Follow-up Observational Study After Clinical Trials of AMG531 (Romiplostim) in Patients With Untreated Aplastic Anemia
NCT04870346 ·Status: ACTIVE_NOT_RECRUITING
-
Avatrombopag Combined With IST as First-line Treatment for SAA
NCT05720234 ·Status: UNKNOWN ·Phase: PHASE2
-
The International ITP Registry
NCT01970189 ·Status: UNKNOWN
-
Longitudinal Cohort Study on Immune Thrombocytopenia Complicated With Acute Ischemic Stroke
NCT07070193 ·Status: NOT_YET_RECRUITING
-
A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients
NCT00922883 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Hetrombopag in Non-severe Aplastic Anemia
NCT05018936 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Avatrombopag Combined With IST for the Treatment of HAAA and SAA With Abnormal Liver Function
NCT05571332 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Eltrombopag + Tacrolimus in Chinese Refractory or Relapsed Aplastic Anemia Patients
NCT04403321 ·Status: COMPLETED ·Phase: PHASE2
-
Role of ROTEM and Platelet Indices in Thrombocytopenic Patients .
NCT05850481 ·Status: UNKNOWN
-
Cold Versus Room Temperature Storage of Platelets for Bleeding in Hematologic Malignancy - a Pilot Trial
NCT05820126 ·Status: RECRUITING ·Phase: PHASE2
-
Study Assessed the Safety and Efficacy of Eltrombopag in Chinese Refractory or Relapsed Severe Aplastic Anemia (SAA) Subjects.
NCT03988608 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia
NCT02857530 ·Status: UNKNOWN ·Phase: PHASE2
-
Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness
NCT06254560 ·Status: RECRUITING ·Phase: PHASE2
-
Real-world Outcomes of Aplastic Anemia Patients Treated With Eltrombopag: A Medical Claims Database Study
NCT06991894 ·Status: COMPLETED
-
Eltrombopag for Moderate Aplastic Anemia
NCT01328587 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of CSA and Avatrombopag for the Treatment of SAA in the Elderly
NCT05433922 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia (EMAA)
NCT02773225 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effectiveness of Early Intervention in Transfusion Independent Aplastic Anemia: a Retrospective Medical Claims Database Study
NCT06669221 ·Status: COMPLETED
-
The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP
NCT03377439 ·Status: UNKNOWN
-
Value of Platelet Indices as Predictive Factor in Thrombocytopenia
NCT05116033 ·Status: UNKNOWN
-
Extension Study of Hetrombopag in Severe Aplastic Anemia
NCT04961710 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP
NCT05369208 ·Status: COMPLETED ·Phase: PHASE3